We need to enhance our capacity to analyze large amounts of high-dimensional ‘omic data emerging from our rapidly growing number of translational and clinical research projects. We chose Genedata because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines.
Kimio Terao Department Manager of Clinical Pharmacology
We aimed to extend automation and further enhance the efficiency of our cell line, upstream and bioanalytical development operations, and quickly realized that Genedata addresses many of our requirements off-the-shelf, eliminating the need for expensive customization.
To optimally handle the complex data, we need a centralized genome knowledge management and analysis solution that addresses the interdisciplinary challenges in next-generation biotechnology innovations. Genedata was our obvious choice.
Harald Bradl, Ph.D. Director, Cell Culture and Process Sciences
Genedata enables us to integrate a wide variety of complex data generated by novel experimental workflows so we can gain a holistic molecular understanding of production cells with the goal of developing high performing bioproduction processes.
Ruth Wagner, Ph.D. Group Manager of Cell Line Engineering
After reviewing the options available to us, we concluded that Genedata Screener matches perfectly with our vision of being totally compatible with other digital innovation initiatives currently ongoing at Servier
Jean-Philippe Stephan, Ph.D. Director, Center of Excellence Pharmacological Screening, Compound Management and Biobanking
The Biologics Data Platform supports our scientists in a complex, multi-site environment by providing all the necessary information and tools to streamline the biologics lead generation and optimization process.
Heiner Apeler, Ph.D. Director of Molecular and Antibody Biology